KPCB XIII Associates’s Progyny PGNY Stock Holding History

KPCB XIII Associates’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$173M	Hold	5,074,615	–	–	92.97%	1
2023 Q2	$200M	Sell	5,074,615 -1,398,900	-22%	-$50.5M	89.23%	1
2023 Q1	$208M	Hold	6,473,515	–	–	91.96%	1
2022 Q4	$202M	Buy	+6,473,515	New	+$234M	96.01%	1
2021 Q3	$415M	Hold	7,406,115	–	–	82.73%	1
2021 Q2	$437M	Sell	7,406,115 -889,781	-11%	-$50M	80.41%	1
2021 Q1	$369M	Sell	8,295,896 -2,797,800	-25%	-$131M	75.9%	1
2020 Q4	$470M	Buy	+11,093,696	New	+$361M	76.02%	1

Other funds holding PGNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

KPCB XIII Associates's PGNY Position: Q3 2023 in Review

KPCB XIII Associates held its Progyny (PGNY) position steady in Q3 2023 at 5,074,615 shares worth $173M. The position accounts for 92.97% of the portfolio, ranked #1.

KPCB XIII Associates first reported a position in PGNY in Q4 2020 and has held it in 8 quarters since. The position peaked at $470M in Q4 2020. 321 funds tracked by Wall St. Rank hold PGNY as of Q3 2023.

KPCB XIII Associates held 5,074,615 shares of Progyny worth $173M as of Q3 2023.
KPCB XIII Associates left its Progyny share count unchanged in Q3 2023.
Progyny made up 92.97% of KPCB XIII Associates's portfolio in Q3 2023, its #1 holding.
KPCB XIII Associates first reported a position in Progyny in Q4 2020 and has held it in 8 quarters since.
KPCB XIII Associates's Progyny position peaked at $470M in Q4 2020.
321 funds tracked by Wall St. Rank held Progyny as of Q3 2023.

Based on KPCB XIII Associates's 13F filing for Q3 2023, filed 8 Nov 2023.